SubHero Banner
Text

Tresiba® (insulin degludec) – Expanded Indication

December 19, 2016 – Novo Nordisk announced the FDA approval of Tresiba (insulin degludec) to improve glycemic control in patients 1 year of age and older with diabetes mellitus.

Download PDF